AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 19:59

Syntara's Valuation Assumes $750 Million Licensing Deal for Drug Candidate, Eruoz Hartleys Says

MT NewswiresMar 28 10:48

Syntara Started at Spec Buy by Euroz Hartleys >SNT.AU

Dow JonesMar 27 06:33

Syntara Develops Drug Candidate for Hypertrophic Scars, Shares Rise 3%

MT NewswiresMar 18 13:04

Syntara Ltd: Half Year Report and Appendix 4D

ASXFeb 26 12:18 · Announcements

Syntara Target Price Raised 20% to A$0.12/Share by Bell Potter>SNT.AU

Dow JonesDec 18, 2024 08:28